Proton magnetic resonance spectroscopic evidence of glial effects of cumulative lead exposure in the adult human hippocampus

Environmental Health Perspectives

Volumn 115, Issue 4, 2007, Pages 519-523

  Weisskopf, Marc G ^a   Hu, Howard ^a,b   Sparrow, David ^b,c,d   Lenkinski, Robert E ^e   Wright, Robert O ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Bone lead; Choline; Glia; Hippocampus; Myoinositol; N acetylaspartate; Neuronal viability; Proton MRS

Indexed keywords

CHOLINE; CREATINE; INOSITOL; LEAD; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; GLIA; HIPPOCAMPUS; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLITE; NERVE CELL; PATELLA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY ANALYSIS; TIBIA; X RAY FLUORESCENCE;

AGED; ASPARTIC ACID; BONE AND BONES; CHOLINE; CREATINE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HIPPOCAMPUS; HUMANS; INOSITOL; LEAD; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS;

EID: 34247157382     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9645     Document Type: Article

References (38)

1. Balbus-Kornfeld JM, Stewart W, Bolla KI, Schwartz BS. 1995. Cumulative exposure to inorganic lead and neurobehavioural test performance in adults: an epidemiological review. Occup Environ Med 52(1):2-12.
2. Banks EC, Ferretti LE, Shucard DW. 1997. Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology 18(1):237-281.
3. Bell B, Rose CL, Damon A. 1966. The Veterans Administration longitudinal study of healthy aging. Gerontologist 6(4):179-184.
4. Bleecker ML, Lindgren KN, Ford DP. 1997. Differential contribution of current and cumulative indices of lead dose to neuropsychological performance by age. Neurology 48(3):639-645.
5. Brand A, Richter-Landsberg C, Leibfritz D. 1993. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15(3-5):289-298.
6. Canfield RL, Henderson CR Jr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. 2003. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 348(16):1517-1526.
7. Fiedler N, Weisel C, Lynch R, Kelly-McNeil K, Wedeen R, Jones K, et al. 2003. Cognitive effects of chronic exposure to lead and solvents. Am J Ind Med 44(4):413-423.
8. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198.
9. Hu H, Aro A, Payton M, Korrick S, Sparrow D, Weiss ST, et al. 1996. The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA 275(15):1171-1176.
10. Hu H, Rabinowitz M, Smith D. 1998. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106:1-8.
11. Kantarci K, Jack CR, Jr., Xu YC, Campeau NG, O'Brien PC, Smith GE, et al. 2000. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 55(2):210-217.
12. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, et al. 2004. 1H MR spectroscopy in common dementias. Neurology 63(8):1393-1398.
13. Kim R, Landrigan C, Mossmann P, Sparrow D, Hu H. 1997. Age and secular trends in bone lead levels in middle-aged and elderly men: three-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol 146(7):586-591.
14. 1H MR spectra of human muscle based on oral creatine supplementation. Magn Reson Med 37(2):159-163.
15. Lindahl LS, Bird L, Legare ME, Mikeska G, Bratton GR, Tiffany-Castiglioni E. 1999. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol Sci 50(2):236-243.
16. Mackenzie IR, Hao C, Munoz DG. 1995. Role of microglia in senile plaque formation. Neurobiol Aging 16(5):797-804.
17. 1H MRS of hippocampus and frontal lobes in children. Neurology 64(9):1644-1647.
18. Morris JC, Price AL. 2001. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 17(2):101-118.
19. Muldoon SB, Cauley JA, Kuller LH, Morrow L, Needleman HL, Scott J, et al. 1996. Effects of blood lead levels on cognitive function of older women. Neuroepidemiology 15(2):62-72.
20. National Center for Environmental Health. 2005. Third National Report on Human Exposure to Environmental Chemicals NCEH Pub. No. 05-0570. Atlanta, GA:Centers for Disease Control and Prevention.
21. Needleman HL, Gatsonis CA. 1990. Low-level lead exposure and the IQ of children. A meta-analysis of modern studies. JAMA 263(5):673-678.
22. Payton M, Riggs KM, Spiro A, 3rd, Weiss ST, Hu H. 1998. Relations of bone and blood lead to cognitive function: the VA Normative Aging Study. Neurotoxicol Teratol 20(1):19-27.
23. 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed 4(2):59-63.
24. Ross BD, Coletti P, Lin A. 2006. Magnetic resonance spectroscopy of the brain: neurospectroscopy. In: Clinical Magnetic Resonance Imaging (Edelman RR, Hesselink JR, Zlatkin MB, Crues JV, eds). Philadelphia:Saunders Elsevier, 1840-1907.
25. Schwartz BS, Stewart WF. 2000. Different associations of blood lead, meso 2,3-dimercaptosuccinic acid (DMSA)-chelatable lead, and tibial lead levels with blood pressure in 543 former organolead manufacturing workers. Arch Environ Health 55(2):85-92.
26. Schwartz J. 1994. Low-level lead exposure and children's IQ: a meta-analysis and search for a threshold. Environ Res 65(1): 42-55.
27. Selvin-Testa A, Loidl CF, Lopez-Costa JJ, Lopez EM, Pecci-Saavedra J. 1994. Chronic lead exposure induces astrogliosis in hippocampus and cerebellum. Neurotoxicology 15(2):389-401.
28. Silverstone PH, McGrath BM, Kim H. 2005. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord 7(1):1-10.
29. Stewart WF, Schwartz BS, Simon D, Bolla KI, Todd AC, Links J. 1999. Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers. Neurology 52(8):1610-1617.
30. Struzynska L, Chalimoniuk M, Sulkowski G. 2005. The role of astroglia in Pb-exposed adult rat brain with respect to glutamate toxicity. Toxicology 212(2-3):185-194.
31. Tiffany-Castiglioni E, Sierra EM, Wu JN, Rowles TK. 1989. Lead toxicity in neuroglia. Neurotoxicology 10(3):417-443.
32. Trope I, Lopez-Villegas D, Cecil KM, Lenkinski RE. 2001. Exposure to lead appears to selectively alter metabolism of cortical gray matter. Pediatrics 107(6):1437-1442.
33. Trope I, Lopez-Villegas D, Lenkinski RE. 1998. Magnetic resonance imaging and spectroscopy of regional brain structure in a 10-year-old boy with elevated blood lead levels. Pediatrics 101(6):1066-1067.
34. Weisskopf MG, Hu H, Mulkern RV, White R, Aro A, Oliveira S, et al. 2004a. Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning. Environ Health Perspect 112:620-625.
35. Weisskopf MG, Proctor SP, Wright RO, Schwartz J, Spiro A, Sparrow D, et al. 2007. Prospective study of cumulative lead exposure and performance in different cognitive domains among elderly men: the VA Normative Aging Study. Epidemiology 18(1):59-66.
36. Weisskopf MG, Wright RO, Schwartz J, Spiro A, Sparrow D, Aro A, et al. 2004b. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol 160(12):1184-1193.
37. West MJ, Kawas CH, Stewart WF, Rudow GL, Troncoso JC. 2004. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol Aging 25(9):1205-1212.
38. Wright RO, Tsaih SW, Schwartz J, Spiro A III, McDonald K, Weiss ST, et al. 2003. Lead exposure biomarkers and minimental status exam scores in older men. Epidemiology 14(6):713-718.